Sanofi and Lonza JV to build 200 person biologics facility in Visp
Sanofi and Lonza will construct a large-scale mammalian cell culture manufacturing site in Switzerland, with an initial investment of CHF 290m ($288m).
News & Analysis on the Clinical Development and Manufacture of Large Molecule Drugs